CROI 2019 Program and Conference Information

Poster Sessions

G. CLINICAL PHARMACOLOGY P-G1

OBJECTIVE ASSESSMENT OF ADHERENCE FOR PrEP AND ART (Tuesday) ARV AND ANTIHEPATITIS PHARMACOKINETICS, PHARMACOGENETICS, AND DRUG INTERACTIONS (Wednesday) P-G3 ARV PHARMACOLOGY IN COMPARTMENTS AND RESERVOIRS (Thursday) H. ANTIRETROVIRAL THERAPY: PRE-CLINICAL DATA, RANDOMIZED TRIALS, EFFICACY AND EFFECTIVENESS STUDIES P-H1 NOVEL ANTIRETROVIRAL AGENTS AND FORMULATIONS (Thursday) P-H2 IT TAKES TWO BABY(?): TWO DRUG ART (Thursday) P-H3 VIROLOGIC FAILURES: TO SECOND LINE AND BEYOND (Wednesday) P-H4 SECONDARY ANALYSIS AND DESIGN ISSUES IN CLINICAL TRIALS AND OBSERVATION STUDIES (Wednesday) P-H5 STRATEGIES: OLD AND NEW (Wednesday) P-H6 WOMEN AND HIV: ARE OUTCOMES DIFFERENT? (Tuesday) P-H7 ACUTE INFECTION AND HIV TRANSMISSION (Tuesday) I. HIV DRUG RESISTANCE P-I1 RESISTANCE SPREAD AND ITS IMPACT ON ART (Tuesday) P-I2 PREVALENCE AND SPREAD OF RESISTANCE (Tuesday) P-I3 NEWMECHANISMS OF RESISTANCE AND NEW DETECTION METHODS (Wednesday) P-I4 ACTIVITY OF DRUGS AGAINST RESISTANT VIRUS (Wednesday) J. HIV DIAGNOSTICS P-J1 HIV DIAGNOSTICS: IT'S FOR THE VIRUS, STUPID (Thursday) K. HEPATITIS VIRUSES AND LIVER COMPLICATIONS P-K1 HCV THERAPEUTICS: REALITY TESTING (Tuesday) P-K2 HCV THERAPEUTICS: MOVING FROM TREATING THE PERSON TO TREATING THE POPULATION (Tuesday) P-K3 HCV TRANSMISSON: THE (MOLECULAR) WEBS WE WEAVE (Wednesday) P-K4 HCV AND HIV: CANCER INFLAMMATION AND FIBROSIS (Wednesday) P-K5 HIV AND HBV INFECTION (Thursday) P-K6 HIV AND HBV: BAD (LIVER) BEDFELLOWS (Thursday) L. AIDS-RELATEDMALIGNANCIES HAS BEEN INTEGRATED INTO C. HIV- ASSOCIATED TUMOR VIRUSES AND AIDS-RELATEDMALIGNANCIES M. CARDIOVASCULAR COMPLICATIONS OF HIV INFECTION AND ANTIRETROVIRAL THERAPY P-M1 NOVEL MEASURES AND DRIVERS OF INFLAMMATION AND VASCULAR FUNCTION (Tuesday) P-M2 COAGULATION ABNORMALITIES IN HIV: WHAT'S THE CLOT GOT TO DO WITH IT? (Tuesday) P-M3 BEYOND TRADITIONAL RISK FACTORS: MECHANISMS OF VASCULAR DISEASE IN HIV (Wednesday) P-M4 ALL THINGS LIPIDS (Wednesday) P-M5 ENDOTHELIAL DYSFUNCTIONS: THE VIRUS, ART, AND OTHER FACTORS (Wednesday) P-M6 HEART FAILURE AND PULMONARY DISEASE (Thursday) P-M7 CARDIOVASCULAR DISEASE: MORTALITY, RISK FACTORS, AND MANAGEMENT STRATEGIES (Thursday) P-G2

Poster Sessions

CROI 2019 159